An open-label study in patients with iron deficiency anemia
Phase 3
Completed
- Conditions
- Iron Deficiency Anemia
- Registration Number
- JPRN-jRCT2080223943
- Lead Sponsor
- Japan Tobacco Inc.
- Brief Summary
The efficacy and safety of JTT-751 were confirmed in patients with iron deficiency anemia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 73
Inclusion Criteria
Iron deficiency anemia
Hemoglobin level of >= 8.0 g/dL and < 11.0 g/d
Exclusion Criteria
* Anemia caused by other than iron deficiency
* Serum phosphate < 2.5 mg/dL or >= 4.5 mg/dL
* Patients scheduled surgical treatment for gynecological diseases with hypermenorrhea during participation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method